The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Randomized trial of modafinil for treating subjective daytime sleepiness in patients with Parkinson's disease
Abstract
We assessed the safety and efficacy of modafinil for the treatment of excessive daytime sleepiness in patients with Parkinson's disease (PD). This was a single‐site, randomized, double‐blind, placebo‐controlled crossover study of 21 PD patients having an Epworth Sleepiness Scale (ESS) score ≥10. They received either placebo or modafinil 200 mg/day for 3 weeks, followed by a washout week, then the alternate treatment for 3 weeks. The ESS data demonstrated a carryover effect, so the changes from baseline ESS scores were compared between the two treatments for period 1 only. The ESS scores for the placebo group went from 16.0 ± 4.2 (mean ± SD) to 17.0 ± 5.1 and for the modafinil group went from 17.8 ± 4.2 to 14.4 ± 5.7 (P = 0.039). There was no significant carryover effect for any other measure. The patient Clinical Global Impression of Change (+3 to −3) improved by 0.75 on modafinil compared with 0.15 for placebo (P = 0.07). A total of 7 of 20 (35%) of the patients reported some improvement on modafinil but not placebo. There was no significant improvement or worsening of the UPDRS subscores I–III, Timed Tap test, or time on. Vital signs, electrocardiograms, and lab tests were unchanged. Modafinil was very well tolerated. Our data demonstrate that, in a small sample size, administration of 200 mg/day of modafinil was associated with few side effects and was modestly effective for the treatment of excessive daytime sleepiness in patients with PD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
A New Method for Measuring Daytime Sleepiness: The Epworth Sleepiness Scale
Johns, M. W. (1991) · Sleep · doi:10.1093/sleep/14.6.540 · Cited by 17,364
Parkinsonism: onset, progression, and mortality
Hoehn, M. M., & Yahr, M. D. (1967) · Neurology · doi:10.1212/wnl.17.5.427 · Cited by 12,107
Krupp, L. B. (1989) · Archives of Neurology · doi:10.1001/archneur.1989.00520460115022 · Cited by 6,172
Recent Developments in Parkinson's Disease
Hurtig, H. I. (1987) · Neurology · doi:10.1212/wnl.37.5.893 · Cited by 1,920
Falling asleep at the wheel: Motor vehicle mishaps in persons taking pramipexole and ropinirole
Frucht, S., Rogers, J. D., Greene, P. E., Gordon, M. F., & Fahn, S. (1999) · Neurology · doi:10.1212/wnl.52.9.1908 · Cited by 692
The measurement of fatigue: a new instrument
Schwartz, J. E., Jandorf, L., & Krupp, L. B. (1993) · Journal of Psychosomatic Research · doi:10.1016/0022-3999(93)90104-n · Cited by 562
The “On–Off” Phenomenon in Parkinson’s Disease: Relation to Levodopa Absorption and Transport
Nutt, J. G., Woodward, W. R., Hammerstad, J. P., Carter, J. H., & Anderson, J. L. (1984) · New England Journal of Medicine · doi:10.1056/nejm198402233100802 · Cited by 554
Hobson, D. E., Lang, A. E., Martin, W. R. W., Razmy, A., Rivest, J., & Fleming, J. (2002) · JAMA · doi:10.1001/jama.287.4.455 · Cited by 553
Randomized trial of modafinil for the treatment of pathological somnolence in narcolepsy
Fry, & US Modafinil in Narcolepsy Multicenter Study Group (1998) · Annals of Neurology · doi:10.1002/ana.410430115 · Cited by 396
The Epworth Sleepiness Scale may not reflect objective measures of sleepiness or sleep apnea
Chervin, R. D., & Aldrich, M. S. (1999) · Neurology · doi:10.1212/wnl.52.1.125 · Cited by 395
Randomized trial of modafinil as a treatment for the excessive daytime somnolence of narcolepsy
US Modafinil in Narcolepsy Multicenter Study Group (2000) · Neurology · doi:10.1212/wnl.54.5.1166 · Cited by 362
Broughton, R. J., Fleming, J. A. E., George, C. F. P., Hill, J. D., Kryger, M. H., Moldofsky, H., Montplaisir, J. Y., Morehouse, R. L., Moscovitch, A., & Murphy, W. F. (1997) · Neurology · doi:10.1212/wnl.49.2.444 · Cited by 288
Excessive daytime sleepiness and sleep benefit in Parkinson's disease: A community-based study
Tandberg, E., Larsen, J. P., & Karlsen, K. (1999) · Movement Disorders · doi:10.1002/1531-8257(199911)14:6<922::aid-mds1003>3.0.co;2-7 · Cited by 287
Daytime sleepiness in Parkinson’s disease
Rye, D. B., Bliwise, D. L., Dihenia, B., & Gurecki, P. (2000) · Journal of Sleep Research · doi:10.1046/j.1365-2869.2000.00201.x · Cited by 260
Fatigue in Parkinson's disease
Friedman, J., & Friedman, H. (1993) · Neurology · doi:10.1212/wnl.43.10.2016 · Cited by 230
Sleep, excessive daytime sleepiness and fatigue in Parkinson's disease
van Hilten, J. J., Weggeman, M., van der Velde, E. A., Kerkhof, G. A., van Dijk, J. G., & Roos, R. A. C. (1993) · Journal of Neural Transmission - Parkinson's Disease and Dementia Section · doi:10.1007/bf02257678 · Cited by 205
PIGEAU, R., NAITOH, P., BUGUET, A., McCANN, C., BARANSKI, J., TAYLOR, M., THOMPSON, M., & MACK, I. (1995) · Journal of Sleep Research · doi:10.1111/j.1365-2869.1995.tb00172.x · Cited by 191
Benbadis, S. R., Mascha, E., Perry, M. C., Wolgamuth, B. R., Smolley, L. A., & Dinner, D. S. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-4-199902160-00014 · Cited by 190
Pramipexole-induced somnolence and episodes of daytime sleep
Hauser, R. A., Gauger, L., Anderson, W. M., & Zesiewicz, T. A. (2000) · Movement Disorders · doi:10.1002/1531-8257(200007)15:4<658::aid-mds1009>3.0.co;2-n · Cited by 162
Sudden daytime sleep onset in Parkinson's disease: Polysomnographic recordings
Tracik, F. M., & Ebersbach, G. (2001) · Movement Disorders · doi:10.1002/mds.1083 · Cited by 80
Sleep episodes in Parkinson's disease: A wake-up call
Frucht, S. J., Greene, P. E., & Fahn, S. (2000) · Movement Disorders · doi:10.1002/1531-8257(200007)15:4<601::aid-mds1003>3.0.co;2-q · Cited by 78
Polysomnographic characterization of pergolide-induced sleep attacks in idiopathic PD
Ulivelli, M., Rossi, S., Lombardi, C., Bartalini, S., Rocchi, R., Giannini, F., Passero, S. G., Battistini, N., & Lugaresi, E. (2002) · Neurology · doi:10.1212/wnl.58.3.462 · Cited by 71
Methods of Testing for Sleeplessness
Mitler, M. M., & Miller, J. C. (1996) · Behavioral Medicine · doi:10.1080/08964289.1996.9933755 · Cited by 63
Fuxé, K., Janson, A. M., Rosén, L., Finnman, U.-B., Tanganelli, S., Morari, M., Goldstein, M., & Agnati, L. F. (1992) · Experimental Brain Research · doi:10.1007/bf02259133 · Cited by 56
Daytime somnolence in patients with Parkinson's disease
Sanjiv, C. C., Schulzer, M., Mak, E., Fleming, J., Martin, W. R. W., Brown, T., Calne, S. M., Tsui, J. K. C., Stoessl, A. J., Lee, C. S., et al. (2001) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(00)00076-6 · Cited by 46
Ueki, A., Ros�n, L., Andbjer, B., Finnman, U.-B., Altamimi, U., Janson, A. M., Goldstein, M., Agnati, L. F., & Fuxé, K. (1993) · Experimental Brain Research · doi:10.1007/bf00228393 · Cited by 32
Cited by
Samii, A., Nutt, J. G., & Ransom, B. R. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16305-8 · Cited by 1,265
Seppi, K., Weintraub, D., Coelho, M., Perez‐Lloret, S., Fox, S. H., Katzenschlager, R., Hametner, E., Poewe, W., Rascol, O., Goetz, C. G., et al. (2011) · Movement Disorders · doi:10.1002/mds.23884 · Cited by 1,141
The scientific and clinical basis for the treatment of Parkinson disease (2009)
Olanow, C. W., Stern, M. B., & Sethi, K. (2009) · Neurology · doi:10.1212/wnl.0b013e3181a1d44c · Cited by 908
Neuropsychiatric symptoms in Parkinson's disease
Aarsland, D., Marsh, L., & Schrag, A. (2009) · Movement Disorders · doi:10.1002/mds.22589 · Cited by 557
Millan, M. J. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.11.006 · Cited by 551
Metadata
- Authors
- Adler, C. H., Caviness, J. N., Hentz, J. G., Lind, M., & Tiede, J.
- Venue
- Movement Disorders
- Publisher
- Wiley
- Published
- 2002-12-05
- Volume
- 18
- Issue
- 3
- Pages
- 287-293
- ISSN
- 0885-3185 (ISSN-L)
- 1531-8257
- OpenAlex
- W2012540611
- Cited by
- 272
- References
- 27
- FWCI
- 5.44
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.